H. Au
Impact in
- Oncology top 1%
- Pancreatic and Hepatic Oncology Research
- Cancer survivorship and care
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Cancer Research top 10%
Papers in
- Oncology 8
- Pancreatic and Hepatic Oncology Research 4
- Cancer survivorship and care 3
- Cancer Treatment and Pharmacology 1
-
- Bacterial Infections and Vaccines 2
- Co-authors
- Malcolm J. Moore (4 shared papers)Wendy R. Parulekar (3 shared papers)David Goldstein (3 shared papers)Arié Figer (2 shared papers)P. Murawa (2 shared papers)Robert S. C. Lim (2 shared papers)David Walde (2 shared papers)Joel Randolph Hecht (2 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)Quality of Life Research (2 papers)Social Science & Medicine (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)Canadian Medical Association Journal (1 paper)
- Partner nations
- CanadaAustraliaUnited States
In The Last Decade
H. Au
13 papers receiving 3.5k citations
H. Au's Hit Papers
Peers
Comparison fields: 5 of 81
- Oncology 2.7k
- Cancer Research 123
- Pulmonary and Respiratory Medicine 234
- Dermatology 51
- Biomaterials 68
Countries citing papers authored by H. Au
This map shows the geographic impact of H. Au's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Au with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Au more than expected).
Fields of papers citing papers by H. Au
This network shows the impact of papers produced by H. Au. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Au. The network helps show where H. Au may publish in the future.
Co-authors
The 25 scholars most cited alongside H. Au, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group Hit paper breakdown → | 2007 | 3124 |
| 2 | 2008 | 153 | |
| 3 | 2009 | 123 | |
| 4 | 2004 | 60 | |
| 5 | 2011 | 41 | |
| 6 | Docetaxel (Taxotere) in combination with anthracyclines in the treatment of breast cancer. | 2000 | 28 |
| 7 | 2014 | 28 | |
| 8 | 1999 | 26 | |
| 9 | 2023 | 20 | |
| 10 | 2016 | 13 | |
| 11 | 2014 | 5 | |
| 12 | 2006 | 4 | |
| 13 | 2011 | 3 |
About H. Au
H. Au is a scholar working on Oncology, Microbiology, Pulmonary and Respiratory Medicine, Surgery and Economics and Econometrics, having authored 13 papers that have together received 3.6k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (4 papers), Cancer survivorship and care (3 papers), Bacterial Infections and Vaccines (2 papers), Lung Cancer Diagnosis and Treatment (1 paper), Spinal Dysraphism and Malformations (1 paper), Cancer Treatment and Pharmacology (1 paper), Esophageal Cancer Research and Treatment (1 paper) and Infectious Diseases and Tuberculosis (1 paper). The work is most often cited by research in Oncology (2.7k citations), Cancer Research (123 citations), Pulmonary and Respiratory Medicine (234 citations), Dermatology (51 citations) and Biomaterials (68 citations). H. Au has collaborated with scholars based in Canada, Australia and United States. Frequent co-authors include Malcolm J. Moore, Wendy R. Parulekar, David Goldstein, Arié Figer, P. Murawa, Robert S. C. Lim, David Walde, Joel Randolph Hecht, Steve Gallinger and Robert A. Wolff. Their work appears in journals such as Journal of Clinical Oncology, Quality of Life Research, Social Science & Medicine, International Journal of Radiation Oncology*Biology*Physics and Canadian Medical Association Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.